Pandit, S D <br/><br/>
The multiple endocrine neoplasia type 2B point mutation alters long-term regulation and enhances the transforming capacity of the epidermal growth factor receptor.  [electronic resource] 

 -  The Journal of biological chemistry  Mar 1996 
 - 5850-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0021-9258 
<br/><br/><label>Standard No.: </label>10.1074/jbc.271.10.5850  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3T3 Cells<br/>Amino Acid Sequence<br/>Animals<br/>Base Sequence<br/>Cell Division--drug effects<br/>Cell Line<br/>Cell Transformation, Neoplastic<br/>DNA Primers<br/>Down-Regulation<br/>Drosophila Proteins<br/>Epidermal Growth Factor--metabolism<br/>ErbB Receptors--biosynthesis<br/>Gene Expression Regulation, Neoplastic<br/>Gene Library<br/>Humans<br/>Kinetics<br/>Mice<br/>Molecular Sequence Data<br/>Multiple Endocrine Neoplasia Type 2b--genetics<br/>Mutagenesis, Site-Directed<br/>Peptides--chemical synthesis<br/>Phosphorylation<br/>Plasmids<br/>Point Mutation<br/>Proto-Oncogene Mas<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins c-ret<br/>Proto-Oncogenes<br/>Receptor Protein-Tyrosine Kinases--genetics<br/>Recombinant Proteins--biosynthesis<br/>Substrate Specificity<br/>Tumor Cells, Cultured